Clinical Report: Coding and Billing Updates for Geographic Atrophy Drugs

Overview

Recent advancements in geographic atrophy (GA) treatments necessitate updates in coding and billing practices for optometrists and ophthalmologists. New permanent HCPCS codes have been established for drugs like pegcetacoplan and avacincaptad pegol, emphasizing the importance of accurate billing and documentation.

Background

Geographic atrophy is an advanced form of age-related macular degeneration (AMD) that leads to progressive vision loss. With the introduction of new treatments, it is crucial for healthcare providers to stay updated on coding and billing practices to ensure proper reimbursement and patient care. Accurate documentation is essential to support the medical necessity of treatments and prevent claim denials.

Data Highlights

Key Findings

• New drugs for GA require updates in coding and billing practices.
• Pegcetacoplan transitioned to permanent HCPCS code J2781 as of October 1, 2023.
• Avacincaptad pegol will have a permanent HCPCS code J2782 effective April 1, 2024.
• Billing units are based on drug dosage; pegcetacoplan is 15 billing units for 15 mg.
• CMS requires the use of JW and JZ modifiers for accurate billing of discarded drug amounts.
• Documentation must include medication name, dosage, administration route, and specific ICD-10 codes.

Clinical Implications

Healthcare providers must remain vigilant about coding and billing updates to ensure compliance and optimize reimbursement for GA treatments. Accurate documentation is crucial to support the medical necessity of treatments and to mitigate the risk of claim denials. Providers should also be aware of patient assistance programs to help patients manage treatment costs.

Conclusion

Staying informed about coding and billing practices is essential for healthcare providers managing GA treatments. This ensures timely and appropriate care for patients while navigating the complexities of reimbursement.

References

1. Ophthalmic Professional, Ophthalmic Professional, 2019 -- Coding
2. Ophthalmology Management, Ophthalmology Management, 2018 -- Coding & Reimbursement
3. Ophthalmology Management, Ophthalmology Management, 2006 -- Coding
4. Oregon Health & Science University, Age-Related Macular Degeneration Preferred Practice Pattern® -- Clinical Guidance
5. FDA, FDA Label, 2024 -- Drug Label Information
6. Retinal Physician — CODING Q&A: Coding Changes in 2022
7. Age-Related Macular Degeneration Preferred Practice Pattern® - Oregon Health & Science University
8. label
9. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1410172/pdf